Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Activation of the Jak3 pathway and myeloid differentiation.

Mangan JK, Reddy EP.

Leuk Lymphoma. 2005 Jan;46(1):21-7. Review.

PMID:
15621777
2.

Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells.

Rane SG, Mangan JK, Amanullah A, Wong BC, Vora RK, Liebermann DA, Hoffman B, Graña X, Reddy EP.

Blood. 2002 Oct 15;100(8):2753-62.

4.

Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation.

Mangan JK, Rane SG, Kang AD, Amanullah A, Wong BC, Reddy EP.

Blood. 2004 Jun 1;103(11):4093-101. Epub 2004 Feb 19.

5.
6.

Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.

Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K, Hamilton SR, Amin HM.

Am J Pathol. 2005 Oct;167(4):969-80.

7.

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.

Amin HM, Medeiros LJ, Ma Y, Feretzaki M, Das P, Leventaki V, Rassidakis GZ, O'Connor SL, McDonnell TJ, Lai R.

Oncogene. 2003 Aug 21;22(35):5399-407.

PMID:
12934099
8.

Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway.

Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, Shide K, Kato K, Miyamoto T, Yamashita Y, Oshima Y, Nakajima H, Iwama A, Aoki K, Takase K, Gondo H, Mano H, Harada M.

J Biol Chem. 2005 Apr 1;280(13):12621-9. Epub 2005 Jan 21.

9.

Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.

Verbsky JW, Bach EA, Fang YF, Yang L, Randolph DA, Fields LE.

J Biol Chem. 1996 Jun 14;271(24):13976-80.

10.

Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.

Han Y, Amin HM, Frantz C, Franko B, Lee J, Lin Q, Lai R.

Leukemia. 2006 Sep;20(9):1602-9. Epub 2006 Jul 27.

PMID:
16871283
11.
12.

Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.

Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, Farrar WL.

Cytokine. 1995 Oct;7(7):689-700.

PMID:
8580378
13.

Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.

Mori A, Higashi H, Hoshikawa Y, Imamura M, Asaka M, Hatakeyama M.

Oncogene. 1999 Nov 4;18(46):6209-21.

14.

Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.

Avalos BR, Parker JM, Ware DA, Hunter MG, Sibert KA, Druker BJ.

Exp Hematol. 1997 Feb;25(2):160-8.

PMID:
9015216
17.

p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation.

Khanna-Gupta A, Sun H, Zibello T, Lozovatsky L, Ghosh PK, Link DC, McLemore ML, Berliner N.

J Leukoc Biol. 2006 May;79(5):1011-21.

PMID:
16641140
18.
20.

STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).

de Koning JP, Soede-Bobok AA, Ward AC, Schelen AM, Antonissen C, van Leeuwen D, Löwenberg B, Touw IP.

Oncogene. 2000 Jul 6;19(29):3290-8.

Supplemental Content

Support Center